... Two CMIs are approved to treat oHCM: aficamten (Myqorzo) and mavacamten (Camzyos).Invasive Procedures and SurgeryProcedures and surgeries that may help manage HCM include: Septal myectomy — Open-heart surgery to remove part of the thickened septum (wall between the heart’s chambers) Septal ablation — A procedure that uses alcohol to reduce the heart ...
nHCM vs. oHCM: Key Differences Explained
... Two CMIs are approved to treat oHCM: aficamten (Myqorzo) and mavacamten (Camzyos).Invasive Procedures and SurgeryProcedures and surgeries that may help manage HCM include: Septal myectomy — Open-heart surgery to remove part of the thickened septum (wall between the heart’s chambers) Septal ablation — A procedure that uses alcohol to reduce the heart ...
... Food and Drug Administration (FDA) has approved two myosin inhibitor medicines for people with obstructive HCM: mavacamten (Camzyos) and aficamten (Myqorzo). Your doctor will decide if one of these is right for you based on your symptoms and test results.Several procedures may help, including a septal ablation. ...
Dilated vs. Hypertrophic Cardiomyopathy: How To Tell the Difference
... Food and Drug Administration (FDA) has approved two myosin inhibitor medicines for people with obstructive HCM: mavacamten (Camzyos) and aficamten (Myqorzo). Your doctor will decide if one of these is right for you based on your symptoms and test results.Several procedures may help, including a septal ablation. ...